1. Zhong, Shangwei, Jeong, Ji-Hak, Huang, Changhao, Yang, Li, Luo, Jun-Li. 2021. Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer. In Journal of experimental & clinical cancer research : CR, 40, 307. doi:10.1186/s13046-021-02109-z. https://pubmed.ncbi.nlm.nih.gov/34587977/
2. Zhou, Xincheng, Zou, Bing, Wang, Jian, Tan, Qiang, Ji, Chunyu. 2022. Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma. In Frontiers in genetics, 13, 946848. doi:10.3389/fgene.2022.946848. https://pubmed.ncbi.nlm.nih.gov/36437916/
3. Dean, Jon G, Liu, Tiecheng, Huff, Sean, Wang, Michael M, Borjigin, Jimo. 2019. Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain. In Scientific reports, 9, 9333. doi:10.1038/s41598-019-45812-w. https://pubmed.ncbi.nlm.nih.gov/31249368/
4. Cui, Kun, Yao, Xi, Wei, Zhengbo, Tang, Jinping, Xie, Ying. 2022. Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma. In Frontiers in genetics, 13, 917344. doi:10.3389/fgene.2022.917344. https://pubmed.ncbi.nlm.nih.gov/36186458/
5. Yang, Liliang, Wei, Xinyan, Sun, Piaopiao, Fang, Shencun, Chao, Jie. 2024. Deciphering the spatial organization of fibrotic microenvironment in silica particles-induced pulmonary fibrosis. In Journal of hazardous materials, 478, 135540. doi:10.1016/j.jhazmat.2024.135540. https://pubmed.ncbi.nlm.nih.gov/39178783/
6. Kim, Jason Yongha, Seo, Jeong-Meen, Kim, Dae-Yeon, Kim, Jeong-Hyun, Shin, Hyoung Doo. 2015. Potential Association of INMT Nonsynonymous Variant (His46Pro) with Hirschsprung's Disease. In Neonatology, 108, 164-71. doi:10.1159/000435874. https://pubmed.ncbi.nlm.nih.gov/26183064/